Equities researchers at StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a note issued to investors on Tuesday. The brokerage set a “hold” rating on the stock.
China Pharma Stock Up 5.5 %
Shares of NYSE:CPHI opened at $0.20 on Tuesday. The business has a 50-day moving average price of $0.22 and a 200 day moving average price of $0.29. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.84 and a quick ratio of 0.24. China Pharma has a 12-month low of $0.17 and a 12-month high of $1.21.
China Pharma (NYSE:CPHI – Get Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. The business had revenue of $0.93 million for the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Read More
- Five stocks we like better than China Pharma
- What is the S&P 500 and How It is Distinct from Other Indexes
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Introduction to Fibonacci Retracement Levels
- Dividend Payout Ratio Calculator
- Top 3 Stocks to Outperform the S&P 500 in a Downturn
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
